Work

Specificity of Changes in the Content of Stable Nitric Oxide Metabolites in Experimental Models of Diabetes Mellitus

Year: 2026
Type: article
Abstract: Diabetes mellitus is one of the major medical and social challenges of the 21st century, characterized by its increasing prevalence, high incidence of complications, and substantial burden on healthcare systems. The nitric oxide system has been implicated in the pathogenesis of diabetes mellitus, both through impairment of its physiological functions and through excessive tissue damage caused by toxic end metabolites. Objective. To determine the specific patterns of changes in the levels of stable nitric oxide metabolites (NOx and nitrotyrosine) in blood plasma and brain homogenates in experimental models of type 1 and type 2 diabetes mellitus in adult male Wistar rats. Materials and methods. The experimental part of the study was conducted on 30 mature male Wistar rats, divided into 3 experimental groups of 10 animals each (control group, group with a model of type 1 diabetes mellitus and group with a model of type 2 diabetes mellitus). Total protein was determined using the biuret method. Biochemical analysis of the content of stable NO metabolites in blood plasma and brain homogenates was performed using the Griess method, followed by conversion to μM/g protein. The level of 3-nitrotyrosine in the cytosolic fraction of brain homogenates and blood plasma was assessed using the solid-phase immunoassay method, followed by conversion to ng/g protein. Statistical processing of the study results was performed using the Statistica application software package (descriptive statistics, Shapiro-Wilk test, Brown-Forsythe test, ANOVA, Welch’s ANOVA, Tukey test, Welch’s t-test with Bonferroni adjustment, p < 0.05). Results. The study revealed several important patterns in the specificity of changes in stable nitric oxide metabolites across different types of experimental diabetes mellitus. The highest level of nitrites was recorded in type 1 diabetes mellitus, with an increase of 5.5 times compared to the control. In type 2 diabetes mellitus, the level of NOx was significantly lower than in type 1 diabetes mellitus. The level of 3-nitrotyrosine in the plasma of rats increased by 3.1 times in type 1 diabetes mellitus and by 2.5 times in type 2 diabetes mellitus. Analysis of the indicators of final NO metabolites in brain homogenates revealed an increase in NOx in type 2 diabetes mellitus, 1.7 times higher than in type 1 diabetes mellitus and 21 times higher than in the control. The level of 3-nitrotyrosine in rat brain homogenates increased approximately 1.7-fold in both types of diabetes. Conclusions. Experimental diabetes mellitus of both types is accompanied by a pathological increase in nitric oxide production, which has both systemic (in plasma) and local (in brain tissues) nature. Type 2 diabetes mellitus is characterised by a more aggressive accumulation of NO metabolites in the brain compared to type 1 diabetes mellitus. The biochemical marker 3-nitrotyrosine can be considered a reliable indicator of the severity of neurodegenerative changes in diabetes.
Language: English
Field: Medicine
Open Access status: diamond
OpenAlex ID: W7165048853
FWCI:
Cites: 11
Cited by:
Related to: 10